Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Mar 29;292(6524):864–866. doi: 10.1136/bmj.292.6524.864

Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial.

K Lauritsen, L S Laursen, T Havelund, P Bytzer, L B Svendsen, J Rask-Madsen
PMCID: PMC1339972  PMID: 3083913

Abstract

One hundred and eighty patients with endoscopically proved duodenal ulcers were allocated at random to double blind treatment with the synthetic dehydroprostaglandin E2 enprostil 35 micrograms twice daily or ranitidine 150 mg twice daily for up to six weeks. Patients completed the study if ulcer healing and pain relief had occurred at two or four weeks. A total of 163 patients completed the trial. The duration of treatment was longer in the enprostil group (p less than 0.005) and the cumulative healing rates at two, four, and six weeks were 51%, 74%, and 85%, respectively. In the ranitidine group the corresponding figures were 65% (p less than 0.04), 89% (p less than 0.02), and 99% (p less than 0.002). More patients treated with ranitidine reported relief of pain (p less than 0.004 at weeks 5 and 6). The observed superiority of ranitidine 150 mg twice daily over enprostil 35 micrograms twice daily questions the clinical relevance of using so called "cytoprotection" as treatment for duodenal ulcer disease in the short term.

Full text

PDF
864

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohen M. M., McCready D. R., Clark L., Sevelius H. Protection against aspirin-induced antral and duodenal damage with enprostil. A double-blind endoscopic study. Gastroenterology. 1985 Jan;88(1 Pt 2):382–386. doi: 10.1016/s0016-5085(85)80193-1. [DOI] [PubMed] [Google Scholar]
  2. Lauritsen K., Rune S. J., Bytzer P., Kelbaek H., Jensen K. G., Rask-Madsen J., Bendtsen F., Linde J., Højlund M., Andersen H. H. Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. N Engl J Med. 1985 Apr 11;312(15):958–961. doi: 10.1056/NEJM198504113121505. [DOI] [PubMed] [Google Scholar]
  3. Levine B. A., Sirinek K. R., Gaskill H. V., 3rd Topical prostaglandin E2 in the treatment of acute upper gastrointestinal tract hemorrhage. A prospective, randomized, double-blind study. Arch Surg. 1985 May;120(5):600–604. doi: 10.1001/archsurg.1985.01390290078013. [DOI] [PubMed] [Google Scholar]
  4. Robert A., Lancaster C., Davis J. P., Field S. O., Sinha A. J., Thornburgh B. A. Cytoprotection by prostaglandin occurs in spite of penetration of absolute ethanol into the gastric mucosa. Gastroenterology. 1985 Jan;88(1 Pt 2):328–333. doi: 10.1016/s0016-5085(85)80187-6. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES